0000896262-22-000017.txt : 20220222 0000896262-22-000017.hdr.sgml : 20220222 20220222210852 ACCESSION NUMBER: 0000896262-22-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220217 FILED AS OF DATE: 20220222 DATE AS OF CHANGE: 20220222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bohnert Denise M. CENTRAL INDEX KEY: 0001787283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 22660407 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY, SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 wf-form4_164558210286239.xml FORM 4 X0306 4 2022-02-17 0 0000896262 AMEDISYS INC AMED 0001787283 Bohnert Denise M. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 0 1 0 0 Chief Compliance Officer Common Stock 2022-02-17 4 A 0 873 0 A 13233 D Common Stock 2022-02-20 4 F 0 360 141.07 D 12873 D Common Stock 215 I By 401(k) Plan Stock Option (Right to Buy) 143.25 2022-02-17 4 A 0 2040 0 A 2032-02-17 Common Stock 2040.0 2040 D Restricted Stock Unit (Performance-Based Vesting) 2022-02-17 4 A 0 1746 0 A Common Stock 1746.0 1746 D The Issuer awarded the Reporting Person 873 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to certain pro-rated vesting provisions as provided in the award agreement for the RSUs. The information in this report is based on a plan statement dated as of December 31, 2021. The Stock Options are subject to time-based vesting conditions and will vest in equal, 25% installments on each of February 20, 2023, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date, subject to pro-rated vesting provisions as provided in the award agreement for the Stock Options. The performance-based RSUs will vest based on certification of achievement of an identified performance measure for 2022, with additional time-based vesting in equal 25% installments on each of the certification date and February 20, 2024, 2025 and 2026, assuming the Reporting Person remains continuously employed on the vesting date. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved. /s/ Jennifer R. Guckert, pursuant to a power of attorney 2022-02-22